SPI Pharma has been solving formulation challenges using superior functional materials.
01 2SPI PHARMA
02 1SPI Pharma
03 3SPI Pharma Inc.
04 1SPI Pharma, Inc
05 13SPI Pharma, Inc.
06 1DEAD SEA PERICLASE
07 2Dead Sea Periclase
08 1Hainan Poly Pharm. Co., Ltd.
09 1Hebi Meishen Technology Co., Ltd
01 3Aluminum Hydroxide Magnesium Hydroxide
02 2Aluminum Hydroxide, Magnesium Carbonate
03 2MAGNESIUM HYDROXIDE
04 15Magnesium Hydroxide
05 2Magnesium hydroxide
06 1magnesium hydroxide
01 1China
02 3Israel
03 20U.S.A
04 1Blank
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-188
Start Marketing Date : 2012-12-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-435
Start Marketing Date : 2020-01-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
NDC Package Code : 12784-425
Start Marketing Date : 2015-06-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
NDC Package Code : 12784-330
Start Marketing Date : 2018-12-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (28.6kg/100kg 37.4kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-434
Start Marketing Date : 2020-01-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
NDC Package Code : 12784-424
Start Marketing Date : 2015-06-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-198
Start Marketing Date : 2018-10-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-192
Start Marketing Date : 2021-06-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-196
Start Marketing Date : 2019-05-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (98kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
SPI Pharma has been solving formulation challenges using superior functional materials.
NDC Package Code : 12784-191
Start Marketing Date : 2020-01-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (97kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
17
PharmaCompass offers a list of Magnesium Hydroxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Hydroxide manufacturer or Magnesium Hydroxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Hydroxide manufacturer or Magnesium Hydroxide supplier.
PharmaCompass also assists you with knowing the Magnesium Hydroxide API Price utilized in the formulation of products. Magnesium Hydroxide API Price is not always fixed or binding as the Magnesium Hydroxide Price is obtained through a variety of data sources. The Magnesium Hydroxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Magnesium Hydroxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium Hydroxide, including repackagers and relabelers. The FDA regulates Magnesium Hydroxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium Hydroxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magnesium Hydroxide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magnesium Hydroxide supplier is an individual or a company that provides Magnesium Hydroxide active pharmaceutical ingredient (API) or Magnesium Hydroxide finished formulations upon request. The Magnesium Hydroxide suppliers may include Magnesium Hydroxide API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium Hydroxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Magnesium Hydroxide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Magnesium Hydroxide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Magnesium Hydroxide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Magnesium Hydroxide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Magnesium Hydroxide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Magnesium Hydroxide suppliers with NDC on PharmaCompass.
We have 3 companies offering Magnesium Hydroxide
Get in contact with the supplier of your choice:
